Park Ha Biological Technology ( (BYAH) ) has provided an announcement.

Park Ha Biological Technology said it will implement a 1‑for‑8 reverse stock split of its Class A and Class B ordinary shares, expected to take effect on August 6, 2026, after shareholder and board approvals at an extraordinary general meeting and board meeting held on July 13, 2026. The move follows a recent private placement that closed on August 3, 2026 and share issuances under its 2026 Share Incentive Plan, and is accompanied by an amended and restated charter filed in the Cayman Islands reflecting changes to share capital and par value.

The reverse split will cut the company’s issued and outstanding shares from 18,764,216 to an expected 2,345,527, with fractional entitlements rounded up to the nearest whole share, while preserving the existing dual‑class voting structure and keeping the Nasdaq ticker unchanged but under a new CUSIP. By consolidating shares without altering core security terms, the action is poised to raise the company’s per‑share trading price and align its capital structure with Nasdaq requirements, affecting shareholders’ holdings on a proportional, split‑adjusted basis but not their overall economic interest.